Health Care & Life Sciences » Pharmaceuticals | Wuyi International Pharmaceutical Co. Ltd.

Wuyi International Pharmaceutical Co. Ltd. | Cash Flow

Fiscal year is January-December. All values HKD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
2,585.30
51,846.40
71,017.60
588,179.50
1,193,278.90
217,574.70
Depreciation, Depletion & Amortization
79,189.20
83,643.10
90,469.60
87,467.80
93,425.40
17,488.50
Other Funds
6,778.00
48,661.00
62,681.80
517,177.10
1,067,292.60
158,851.80
Funds from Operations
74,996.50
80,457.80
98,805.50
16,465.40
32,560.90
41,234.40
Changes in Working Capital
4,768.00
29,993.30
11,945.00
60,700.50
176,929.70
42,787.20
Net Operating Cash Flow
70,228.50
50,464.50
86,860.50
44,235.20
209,490.50
1,552.80
Capital Expenditures
357,549.50
90,684.60
113,630.70
508,819.40
235,821.30
Sale of Fixed Assets & Businesses
-
-
94,347.70
99.30
-
Purchase/Sale of Investments
-
-
-
5,725.30
45,969.00
Net Investing Cash Flow
357,549.50
90,684.60
19,283.00
534,044.40
270,156.70
Issuance/Reduction of Debt, Net
18,925.80
-
24,669.60
59,122.00
226,399.40
Net Financing Cash Flow
18,925.80
-
24,669.60
140,086.40
380,760.80
Net Change in Cash
268,395.20
40,220.10
92,247.10
438,193.20
98,886.40
Free Cash Flow
287,321.00
40,220.10
26,770.20
553,054.60
445,311.80
Net Assets from Acquisitions
-
-
-
19,599.10
-
Change in Capital Stock
-
-
-
80,964.40
154,361.40
Exchange Rate Effect
-
-
-
-
73.80
Other Uses
-
-
-
-
80,304.40
Miscellaneous Funds
-
-
-
-
73.80

About Wuyi International Pharmaceutical Co.

View Profile
Address
Unit 5, 7/F., Nanyang Plaza
Hong Kong
Hong Kong
Employees -
Website http://www.1889hk.com
Updated 07/08/2019
Sanai Health Industry Group Co. Ltd. is a pharmaceutical company, which through its subsidiaries, engages in developing, manufacturing, marketing, and sales of pharmaceutical products. It offers branded prescription and over-the-counter Western pharmaceuticals, and modern Chinese medicine products. It focuses on therapeutic drugs for respiratory, cardiovascular, and gastrointestinal diseases, as well as parenteral nutrition, antibiotics, antiviral, and antifungal products.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.